Venrock Associates Vi, L.p. - Net Worth and Insider Trading

Venrock Associates Vi, L.p. Net Worth

The estimated net worth of Venrock Associates Vi, L.p. is at least $32 Million dollars as of 2024-05-21. Venrock Associates Vi, L.p. is the 10% Owner of 10x Genomics Inc and owns about 1,287,825 shares of 10x Genomics Inc (TXG) stock worth over $32 Million. Details can be seen in Venrock Associates Vi, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Venrock Associates Vi, L.p. has not made any transactions after 2020-05-20 and currently still holds the listed stock(s).

Transaction Summary of Venrock Associates Vi, L.p.

Venrock Associates Vi, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Venrock Associates Vi, L.p. owns 3 companies in total, including 10x Genomics Inc (TXG) , Castlight Health Inc (CSLT) , and Adverum Biotechnologies Inc (ADVM) .

Click here to see the complete history of Venrock Associates Vi, L.p.’s form 4 insider trades.

Insider Ownership Summary of Venrock Associates Vi, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
TXG	10x Genomics Inc	2020-09-16	10 percent owner
CSLT	Castlight Health Inc	2022-02-17	10 percent owner
ADVM	Adverum Biotechnologies Inc	2014-07-30	10 percent owner

Venrock Associates Vi, L.p. Latest Holdings Summary

Venrock Associates Vi, L.p. currently owns a total of 1 stock. Venrock Associates Vi, L.p. owns 1,287,825 shares of 10x Genomics Inc (TXG) as of May 20, 2020, with a value of $32 Million.

Latest Holdings of Venrock Associates Vi, L.p.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TXG	10x Genomics Inc	2020-05-20	1,287,825	24.83	31,976,695

Holding Weightings of Venrock Associates Vi, L.p.

Venrock Associates Vi, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Venrock Associates Vi, L.p. has made a total of 1 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 10x Genomics Inc is the sale of 1,013,569 shares on May 20, 2020, which brought Venrock Associates Vi, L.p. around $79 Million.

Insider Trading History of Venrock Associates Vi, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Venrock Associates Vi, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Venrock Associates Vi, L.p. Ownership Network

Ownership Network List of Venrock Associates Vi, L.p.

No Data

Ownership Network Relation of Venrock Associates Vi, L.p.

Venrock Associates Vi, L.p. Owned Company Details

What does 10x Genomics Inc do?

Who are the key executives at 10x Genomics Inc?

Venrock Associates Vi, L.p. is the 10 percent owner of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .

10x Genomics Inc (TXG) Insider Trades Summary

Over the past 18 months, Venrock Associates Vi, L.p. made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 90,937 shares made by Serge Saxonov , a net sale of 36,912 shares made by Benjamin J. Hindson , and a net sale of 9,758 shares made by Justin J. Mcanear .

In summary, during the past 3 months, insiders sold 11,959 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 11,959 shares. During the past 18 months, 208,804 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,804 shares.

10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

10x Genomics Inc Insider Transactions

No Available Data

What does Castlight Health Inc do?

Who are the key executives at Castlight Health Inc?

Venrock Associates Vi, L.p. is the 10 percent owner of Castlight Health Inc. Other key executives at Castlight Health Inc include 10 percent owner Venrock Management Vi, Llc , 10 percent owner Venrock Partners Management Vi, Llc , and 10 percent owner Venrock Partners Vi, L.p. .

Castlight Health Inc (CSLT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Castlight Health Inc (CSLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Castlight Health Inc (CSLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Castlight Health Inc (CSLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Castlight Health Inc Insider Transactions

No Available Data

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Venrock Associates Vi, L.p. is the 10 percent owner of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Venrock Associates Vi, L.p. made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adverum Biotechnologies Inc Insider Transactions

No Available Data

Venrock Associates Vi, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Venrock Associates Vi, L.p.. You might contact Venrock Associates Vi, L.p. via mailing address: 3340 Hillview Avenue, Palo Alto Ca 94304.

Discussions on Venrock Associates Vi, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.